Chronic Urticaria It’S More Than Just Antihistamines! Randy D
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Urticaria - Primary Care Treatment Pathway
DORSET MEDICINES ADVISORY GROUP Urticaria - Primary Care Treatment Pathway Urticaria – also known as hives or nettle rash – is a raised, itchy rash that can occur on just one part of the body or be spread across large areas. The weals of urticaria last less than 24 hours although patients may develop new weals on a daily basis. If urticaria clears completely within six weeks, it is known as acute urticaria. Urticaria occurring for more than six weeks is referred to as chronic urticaria. Most cases of chronic disease occur without an obvious trigger (chronic spontaneous urticaria). Some urticaria has a physical trigger such as pressure (symptomatic dermographism or delayed pressure urticaria), cold or exercise (cholinergic urticaria), or may be drug induced (e.g. by NSAIDS, ACE inhibitors and opioids). All forms of urticaria can be treated with antihistamine although physical urticaria is less likely to respond to treatment than spontaneous urticaria. Most cases of urticaria settle spontaneously within two years but the condition can last for decades in some patients. Referral criteria Refer routinely to dermatology if patients are not responding to standard treatment (see primary care treatment below, up to step 4), they can then be considered for immunomodulation treatment such as ciclosporin (can be very useful for patients thought to have an autoimmune basis for their urticaria), methotrexate or omalizumab. The diagnosis of urticaria is primarily clinical therefore do not routinely refer for allergy testing. The British Association of Dermatologists (BAD) has produced a patient information leaflet which covers this in detail for patients. PRIOR TO SPECIALIST REFERRAL -conduct a full blood count (FBC), erythrocyte sedimentation rate (ESR), thyroid function tests (TFTs), liver function tests (LFTs), and Helicobacter pylori screening (if gastrointestinal symptoms are present). -
Etiology, Classification, and Treatment of Urticaria
CONTINUING MEDICAL EDUCATION Etiology, Classification, and Treatment of Urticaria Kjetil Kristoffer Guldbakke, MD; Amor Khachemoune, MD, CWS GOAL To understand urticaria to better manage patients with the condition OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Discuss the clinical classification of urticaria. 2. Recognize how to diagnose urticaria. 3. Identify treatment options. CME Test on page 50. This article has been peer reviewed and approved Einstein College of Medicine is accredited by by Michael Fisher, MD, Professor of Medicine, the ACCME to provide continuing medical edu- Albert Einstein College of Medicine. Review date: cation for physicians. December 2006. Albert Einstein College of Medicine designates This activity has been planned and imple- this educational activity for a maximum of 1 AMA mented in accordance with the Essential Areas PRA Category 1 CreditTM. Physicians should only and Policies of the Accreditation Council for claim credit commensurate with the extent of their Continuing Medical Education through the participation in the activity. joint sponsorship of Albert Einstein College of This activity has been planned and produced in Medicine and Quadrant HealthCom, Inc. Albert accordance with ACCME Essentials. Drs. Guldbakke and Khachemoune report no conflict of interest. The authors discuss off-label use of colchi- cine, cyclophosphamide, cyclosporine, dapsone, intravenous immunoglobulin, methotrexate, montelukast sodium, nifedipine, plasmapheresis, rofecoxib, sulfasalazine, tacrolimus, thyroxine, and zafirlukast. Dr. Fisher reports no conflict of interest. Urticaria is among the most common skin dis- autoimmune mechanisms are now recognized as a eases. It can be acute, chronic, mediated by a cause of chronic urticaria. A search of the PubMed physical stimulus, or related to contact with an database (US National Library of Medicine) for urticant. -
Local Heat Urticaria
Volume 23 Number 12 | December 2017 Dermatology Online Journal || Case Presentation DOJ 23 (12): 10 Local heat urticaria Forrest White MD, Gabriela Cobos MD, and Nicholas A Soter MD Affiliations: 1 New York University Langone Health, New York Abstract PHYSICAL EXAMINATION: A brisk, mechanical stroke elicited a linear wheal. Five minutes after exposure We present a 38-year-old woman with local heat to hot water, she developed well-demarcated, urticaria confirmed by heat provocation testing. Heat erythematous blanching wheals that covered the urticaria is a rare form of physical urticaria that is distal forearm and entire hand. triggered by exposure to a heat source, such as hot water or sunlight. Although it is commonly localized Conclusion and immediate, generalized and delayed onset forms Physical or inducible urticarias are a group of exist. Treatment options include antihistamines urticarias that are triggered by various external and heat desensitization. A brisk, mechanical stroke physical stimuli, such as mechanical stimuli, pressure, elicited a linear wheal. Five minutes after exposure cold, light, or temperature change. Urticarias due to hot water, she developed well-demarcated, to temperature change include heat urticaria (HU), erythematous blanching wheals that covered the cholinergic urticaria, and cold urticaria. distal forearm and entire hand. HU is a rare form of chronic inducible urticaria, with Keywords: urticaria, local heat urticaria, physical approximately 60 reported cases [1]. In HU, contact urticaria with a heat source such as hot water, sunlight, hot air, radiant heat, or hot objects results in wheal formation Introduction HISTORY: A 38-year-old woman presented to the Skin and Cancer Unit for the evaluation of recurrent, intensely pruritic eruptions that were precipitated by exposure to heat, which included hot water and sunlight. -
Edderm101 CORE DISEASES V2.09
ed.derm.101: core diseases almost everything you need to know to survive dermatology* “Two thirds of what we see is behind our eyes” “Explain, explain,” grumbled Étienne. “If you people can’t name something you’re incapable of seeing it.”— Cortázar, 1966, Hopscotch “Learning results from what the student does and thinks and only from what the student does and thinks. The teacher can advance learning only by influencing what the student does to learn.” Herbert Simon, Nobel Laureate. ! " *the first of many outright lies exaggerations. You need to know skincancer909 too, and ed.derm.101: core concepts, but these are also free. Professor Jonathan Rees FMedSci Grant Chair of Dermatology University of Edinburgh email me reestheskin.me: about me reestheskinblog.me: unreasonable views from the edge of education and medicine skincancer909: an online textbook of skin cancer for medical students V2.09, 25 September 2019 at 13:18 Distributed under a Creative Commons Attribution-Non Commercial ShareAlike 4.0 License !1 Preface The purpose of ed.derm.101: core diseases is to cover all the clinical material that we expect students to know, that is not covered in either ed.derm.101: core concepts or skincancer909. I assume you have already worked your way through ed.derm.101: core concepts (because what follows is heavily dependent on this foundational reading). A few words of advice about studying this aspect of dermatology and ed.derm.101: - It is hard to learn about a disease without some sort of mental image of what it looks like. In skincancer909 I was able to make use of a bespoke library of images that were developed as part of a research project funded by the Wellcome Trust. -
Chinese Herbal Medicine for Chronic Urticaria and Psoriasis Vulgaris: Clinical Evidence and Patient Experience
Chinese Herbal Medicine for Chronic Urticaria and Psoriasis Vulgaris: Clinical Evidence and Patient Experience A thesis submitted in fulfilment of the requirement for the degree of Doctor of Philosophy Jingjie Yu BMed, MMed School of Health & Biomedical Sciences College of Science, Engineering and Health RMIT University August 2017 Declaration I certify that except where due acknowledgement has been made, the work is that of the author alone; the work has not been submitted previously, in whole or in part, to qualify for any other academic award; the content of the thesis is the result of work which has been carried out since the official commencement date of the approved research program; and, any editorial work, paid or unpaid, carried out by a third party is acknowledged. Jingjie Yu __________________ Date 21 August 2017 i Acknowledgements First, I would like to express my deepest gratitude to my parents, Mr Mingzhong Yu and Mrs Fengqiong Lv, for your endless love, encouragement and support throughout these years. I would also like to express my sincere appreciation to my supervisors, Professor Charlie Changli Xue, Professor Chuanjian Lu, Associate Professor Anthony Lin Zhang and Dr Meaghan Coyle. To my joint senior supervisor, Professor Charlie Changli Xue, thank you for providing me the opportunity to undertake a PhD at RMIT University. To my joint senior supervisor, Professor Chuanjian Lu, thank you for teaching me the truth in life and for the guidance you have given me since I stepped into your consultation room in our hospital seven years ago. To my joint associate supervisor Associate Professor Anthony Lin Zhang, I thank you for your continuous guidance and support during my study at RMIT University. -
10 Chronic Urticaria As an Autoimmune Disease
10 Chronic Urticaria as an Autoimmune Disease Michihiro Hide, Malcolm W. Greaves Introduction Urticaria is conventionally classified as acute, intermittent and chronic (Grea- ves 2000a). Acute urticaria which frequently involves an IgE-mediated im- munological mechanism, is common, its causes often recognised by the patient, and will not be considered further. Intermittent urticaria – frequent bouts of unexplained urticaria at intervals of weeks or months – will be dis- cussed here on the same basis as ‘ordinary’ chronic urticaria. The latter is conventionally defined as the occurrence of daily or almost daily whealing for at least six weeks. The etiology of chronic urticaria is usually obscure. The different clinical varieties of chronic urticaria will be briefly considered here, and attention will be devoted to a newly emerged entity – autoimmune chronic urticaria, since establishing this diagnosis has conceptual, prognostic and the- rapeutic implications. Contact urticaria and angioedema without urticaria will not be dealt with in this account. Classification of Chronic Urticaria The clinical subtypes of chronic urticaria are illustrated in the pie-chart of Fig. 1. The frequency of these subtypes is based upon the authors’ experience at the St John’s Institute of Dermatology in UK. Whilst there may well be mi- nor differences, it is likely that the frequency distribution of these subtypes will be essentially similar in most centres in Europe and North America (Grea- ves 1995, 2000b). However, our experience suggests that the incidence of angioedema, especially that complicated by ordinary chronic urticaria is sub- stantially lower in Japan and south Asian countries (unpublished observation). 310 Michihiro Hide and Malcolm W. -
Urticaria and Angioedema
Urticaria and Angioedema This guideline, developed by Robbie Pesek, MD and Allison Burbank, MD, in collaboration with the ANGELS team, on July 23, 2013, is a significantly revised version of the guideline originally developed by Jeremy Bufford, MD. Last reviewed by Robbie Pesek, MD September 14, 2016. Key Points Urticaria and angioedema are common problems and can be caused by both allergic and non- allergic mechanisms. Prompt diagnosis of hereditary angioedema (HAE) is important to prevent morbidity and mortality. Several new therapeutic options are now available. Patients with urticaria and/or angioedema should be referred to an allergist/immunologist for symptoms that are difficult to control, suspicion of HAE, or to rule out suspected allergic triggers. Definition, Assessment, and Diagnosis Definitions Urticaria is a superficial skin reaction consisting of erythematous, raised, blanching, well- circumscribed or confluent pruritic, edematous wheals, often with reflex erythema.1-3 Urticarial lesions are typically pruritic, and wax/wane with resolution of individual lesions within 24 hours. Angioedema is localized swelling of deep dermal, subcutaneous, or submucosal tissue resulting from similar vascular changes that contribute to urticaria.1,2 Angioedema may be pruritic and/or painful and can last for 2-3 days depending on etiology.3 1 Urticaria alone occurs in 50% of patients and is associated with angioedema in 40% of patients. Isolated angioedema occurs in 10% of patients.1,2 Hereditary angioedema (HAE) is a disorder involving defects in complement, coagulation, kinin, and fibrinolytic pathways that results in recurrent episodes of angioedema without urticaria, usually affecting the skin, upper airway, and gastrointestinal tract.4 In children, acute urticaria is more common than chronic forms. -
ALLCHRONIC URTICARIA About ANGIOEDEMA
ALLCHRONIC URTICARIA about& ANGIOEDEMA WHAT IS CHRONIC URTICARIA? may be a result of an immune system disorder. In very rare cases, The term chronic urticaria (CU) is another term for “chronic CU/angioedema can be identified as a reaction to a medication, hives.” Hives are an inflammation of the skin that results from cells food, insect or infection. Even when the cause cannot be identified, in your body releasing histamine and other allergic chemicals into there are common stimuli that may worsen or exacerbate the condi- the bloodstream. They appear as clusters of raised, red or white tion such as: welts that tend to be very itchy. Chronic hives are defined as hives • allergies (food, environmental) • medications that last more than six weeks, or may briefly go away, but often • temperatures (hot and cold) • illnesses recur frequently. About 40% of people with chronic urticaria often • pressure • sun exposure have another condition known as angioedema. There are several subtypes of CU, including cold urticaria, pressure urticaria, and HOW IS CU/ANGIOEDEMA DIAGNOSED? cholinergic urticaria. CU occurs in about 1% of the US population. The diagnosis of CU is based mostly on history of symptoms and physical exam that is done by either your pediatrician or an WHAT ARE THE SYMPTOMS OF CU? allergist. Although there are not specific laboratory tests that can be done to diagnose this condition, there are blood tests and allergy CU presents as hives - small or large patches that may be round, tests that can be done to identify triggers or rule out other condi- irregular shaped, rings, or may change shape throughout the day. -
Urticaria, Angio-Oedema and Anaphylaxis
CME Dermatology Urticaria, angio-oedema and anaphylaxis The simplest working classification is to separate urticarias into four categories (Table 2): Urticarial lesions (ie areas of superficial Clive EH Grattan MA MD FRCP, Consultant ordinary Dermatologist, Norfolk and Norwich swelling) are also seen in skin diseases physical University Hospital, Norwich other than urticaria (eg some drug reac- tions, bullous pemphigoid). In these vasculitic urticaria (urticarial Clin Med JRCPL 2002;2:20–23 conditions, the lesions do not show the vasculitis) rapid fluctuation which characterises contact urticaria. urticaria. They will not be considered Angio-oedema may be a feature of Urticaria, angio-oedema and anaphy- further in this article. most patterns of urticaria and, for the laxis are distinct clinical entities caused Angio-oedema implies deeper vascular most part, can be considered together by transient plasma leakage from small leakage producing swellings predomi- with urticaria. However, it is worth con- blood vessels. When the affected vessels nantly affecting the subcutis. They tend sidering angio-oedema separately when are superficial the result is a raised, itchy to be large, pale and painful rather than it occurs without weals (Table 3) because swelling of the skin known as a weal. red and itchy, and last longer than weals. it may then be a presentation of Involvement of deeper vessels produces Angio-oedema is a cause of distressing C1esterase inhibitor (C1 inh) deficiency tender subcutaneous and submucosal oropharyngeal swellings but may occur or a drug reaction. swellings known as angio-oedema. anywhere on the integument including Generalised plasma exudation leading to the genitalia. shock is a feature of anaphylaxis but also Ordinary urticaria Anaphylaxis is defined by a life-threat- occurs in anaphylactoid reactions and ening fall in blood pressure, difficulty Ordinary urticaria is a useful collective the capillary leak syndrome. -
Urticaria and Angioedema
URTICARIA AND ANGIOEDEMA What are the aims of this leaflet? This leaflet has been written to help you understand more about urticaria and angioedema. It tells you what they are, what causes them, what you can do about them, and where you can find out more about them. What is urticaria and angioedema? Urticaria is common, and affects about 20% of people at some point in their lives. It is also known as hives or nettle rash. The short-lived swellings of urticaria are known as weals (see below) and typically any individual spot will clear within 24 hours although the overall rash may last for longer. Angioedema is a form of urticaria in which there is deeper swelling in the skin, and the swelling may take longer than 24 hours to clear. An affected individual may have urticaria alone, angioedema alone, or both together. Both are caused by the release of histamine from cells in the skin called mast cells. When angioedema occurs in association with urticaria, the two conditions can be considered part of the same process. When angioedema occurs on its own, different causes need to be considered. There are different types of urticaria of which the most common form is called ‘ordinary or idiopathic urticaria’. In this type no cause is usually identified and often patients have hives and angioedema occurring together. Ordinary urticaria with or without angioedema is usually divided into ‘acute’ and ‘chronic’ forms. In ‘acute’ urticaria/angioedema, the episode lasts from a few days up to six weeks. Chronic urticaria, by definition, lasts for more than six weeks. -
FULL TEXT BOOK Scientific Program Lecture Summaries Oral Presentations Poster Presentations 1 INVITATION
FULL TEXT BOOK Scientific Program Lecture Summaries Oral Presentations Poster Presentations 1 INVITATION Dear colleagues, We are pleased to announce the 5th INDERCOS Congress, taking place 12-15 March 2020 in İstanbul-TURKEY. The main topics of this meeting will be “Immunogenetics in Dermatology and Aging”. Through plenaries and parallel workshop sessions, we aim to share insights and experiences and discuss how advances in aesthetic and general dermatology. In order to success this, we have very distinctive international speakers with extensive experience and a range of expertise across aesthetic dermatology and dermatology. Several major histocompatibility complex and nonmajor histocompatibility complex genetic polymorphisms have been identified which may contribute to the inflammatory skin diseases and skin aging. Most of these genetic variants are associated with mechanisms attributed to the pathogenesis of skin disease and aging, including pathways involved in cytokines, chemokine and vitamin regulation and ultraviolet light exposure and other environmental factors. Immunogenetics is a subspeciality of medicine that studies the relationship between genetics and immunology. Immunogenetics helps in understanding the pathogenesis of several autoimmune, malign, infectious skin diseases and also skin aging. 5th INDERCOS congress focuses on the genetic research areas of autoimmune skin diseases such as connective tissue diseases, psoriasis, skin cancers, vasculitis, skin aging and skin infections. Lectures on genetics of cell interaction with immune system, immune response to transplantation, immune based therapies for treatment of cancers and inflammatory skin diseases and aging, antigenic phylogeny of alleles, alloantigens will be discussed. We hope you will be together with us in this fascinating, high quality scientifically educational congress and we look forward to your precious participation and feedback. -
5 Allergic Diseases (And Differential Diagnoses)
Chapter 5 5 Allergic Diseases (and Differential Diagnoses) 5.1 Diseases with Possible IgE Involve- tions (combination of type I and type IVb reac- ment (“Immediate-Type Allergies”) tions). Atopic eczema will be discussed in a separate section (see Sect. 5.5.3). There are many allergic diseases manifesting in The maximal manifestation of IgE-mediated different organs and on the basis of different immediate-type allergic reaction is anaphylax- pathomechanisms (see Sect. 1.3). The most is. In the development of clinical symptoms, common allergies develop via IgE antibodies different organs may be involved and symp- and manifest within minutes to hours after al- toms of well-known allergic diseases of skin lergen contact (“immediate-type reactions”). and mucous membranes [also called “shock Not infrequently, there are biphasic (dual) re- fragments” (Karl Hansen)] may occur accord- action patterns when after a strong immediate ing to the severity (see Sect. 5.1.4). reactioninthecourseof6–12harenewedhy- persensitivity reaction (late-phase reaction, LPR) occurs which is triggered by IgE, but am- 5.1.1 Allergic Rhinitis plified by recruitment of additional cells and 5.1.1.1 Introduction mediators.TheseLPRshavetobedistin- guished from classic delayed-type hypersensi- Apart from being an aesthetic organ, the nose tivity (DTH) reactions (type IV reactions) (see has several very interesting functions (Ta- Sect. 5.5). ble 5.1). It is true that people can live without What may be confusing for the inexperi- breathing through the nose, but disturbance of enced physician is familiar to the allergist: The this function can lead to disease. Here we are same symptoms of immediate-type reactions interested mostly in defense functions against are observed without immune phenomena particles and irritants (physical or chemical) (skin tests or IgE antibodies) being detectable.